PDB0106 | Optimizing the management of patients with virologic non-suppression | Poster exhibition | B5 |
PDB0202 | Darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-naïve (AMBER) and virologically suppressed (EMERALD) patients with neurologic and/or psychiatric comorbidities: Week 96 subgroup analysis | Poster exhibition | B24 |
PDB0203 | Task-shared, nurse-delivered, cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV clinics in Kayelitsha, South Africa: A randomized controlled trial | Poster exhibition | B16 |
PDB0204 | High burden of depression among clients initiating same-day antiretroviral therapy at the Anonymous Clinic, Bangkok Thailand | Poster exhibition | B16 |
PDB0205 | Longitudinal study of neurocognitive disorders and associated structural brain changes in adolescent HIV | Poster exhibition | B56 |
PDB0206 | Assessing neurocognitive functioning among adolescents and young adults with perinatally acquired HIV in Thailand: Support for the NeuroScreen app | Poster exhibition | B8 |
PDB0302 | Incidence and risk factors for STIs among MSM on PrEP - A post-hoc analysis of the ANRS IPERGAY trial | Poster exhibition | B14 |
PDB0303 | Persistently high rates of sexually transmitted infections in the DISCOVER HIV PrEP trial | Poster exhibition | B14 |
PDB0304 | Pooled pharyngeal, rectal and urine samples for the Point-of-Care detection of Chlamydia trachomatis and Neisseria gonorrhoeae by lay-providers in Key Population-Led Health Services in Thailand | Poster exhibition | B8 |
PDB0305 | Cytomegalovirus retinitis in advanced HIV patients: Screening and care in Mozambique | Poster exhibition | B11 |